Financhill
Sell
35

RGLS Quote, Financials, Valuation and Earnings

Last price:
$1.54
Seasonality move :
7.82%
Day range:
$1.46 - $1.62
52-week range:
$1.08 - $3.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.21x
Volume:
196.7K
Avg. volume:
259.6K
1-year change:
24.03%
Market cap:
$104.8M
Revenue:
--
EPS (TTM):
-$1.06

Regulus Therapeutics SEC Filings

Company Filed Form Type Description
RGLS
Regulus Therapeutics
05/09/2024 10-Q 10-Q filing on 05/09/2024 View Form
RGLS
Regulus Therapeutics
11/09/2023 10-Q 10-Q filing on 11/09/2023 View Form
RGLS
Regulus Therapeutics
08/08/2023 10-Q 10-Q filing on 08/08/2023 View Form
RGLS
Regulus Therapeutics
05/11/2023 10-Q 10-Q filing on 05/11/2023 View Form
RGLS
Regulus Therapeutics
11/14/2022 10-Q 10-Q filing on 11/14/2022 View Form
RGLS
Regulus Therapeutics
08/11/2022 10-Q 10-Q filing on 08/11/2022 View Form
RGLS
Regulus Therapeutics
05/13/2022 10-Q 10-Q filing on 05/13/2022 View Form
RGLS
Regulus Therapeutics
11/12/2021 10-Q 10-Q filing on 11/12/2021 View Form
RGLS
Regulus Therapeutics
08/10/2021 10-Q 10-Q filing on 08/10/2021 View Form
RGLS
Regulus Therapeutics
05/14/2021 10-Q 10-Q filing on 05/14/2021 View Form
RGLS
Regulus Therapeutics
11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
RGLS
Regulus Therapeutics
08/13/2020 10-Q 10-Q filing on 08/13/2020 View Form
RGLS
Regulus Therapeutics
05/14/2020 10-Q 10-Q filing on 05/14/2020 View Form
RGLS
Regulus Therapeutics
03/12/2020 10-K 10-K filing on 03/12/2020 View Form
RGLS
Regulus Therapeutics
11/12/2019 10-Q 10-Q filing on 11/12/2019 View Form
RGLS
Regulus Therapeutics
08/08/2019 10-Q 10-Q filing on 08/08/2019 View Form
RGLS
Regulus Therapeutics
05/10/2019 10-Q 10-Q filing on 05/10/2019 View Form
RGLS
Regulus Therapeutics
04/29/2019 10-K 10-K filing on 04/29/2019 View Form
RGLS
Regulus Therapeutics
03/18/2019 10-K 10-K filing on 03/18/2019 View Form
RGLS
Regulus Therapeutics
11/09/2018 10-Q 10-Q filing on 11/09/2018 View Form
RGLS
Regulus Therapeutics
08/09/2018 10-Q 10-Q filing on 08/09/2018 View Form
RGLS
Regulus Therapeutics
05/10/2018 10-Q 10-Q filing on 05/10/2018 View Form
RGLS
Regulus Therapeutics
03/08/2018 10-K 10-K filing on 03/08/2018 View Form
RGLS
Regulus Therapeutics
11/08/2017 10-Q 10-Q filing on 11/08/2017 View Form
RGLS
Regulus Therapeutics
08/02/2017 10-Q 10-Q filing on 08/02/2017 View Form
RGLS
Regulus Therapeutics
05/05/2017 10-Q 10-Q filing on 05/05/2017 View Form
RGLS
Regulus Therapeutics
03/03/2017 10-K 10-K filing on 03/03/2017 View Form
RGLS
Regulus Therapeutics
11/02/2016 10-Q 10-Q filing on 11/02/2016 View Form
RGLS
Regulus Therapeutics
08/03/2016 10-Q 10-Q filing on 08/03/2016 View Form
RGLS
Regulus Therapeutics
05/03/2016 10-Q 10-Q filing on 05/03/2016 View Form
RGLS
Regulus Therapeutics
02/23/2016 10-K 10-K filing on 02/23/2016 View Form
RGLS
Regulus Therapeutics
11/06/2015 10-Q 10-Q filing on 11/06/2015 View Form
RGLS
Regulus Therapeutics
08/05/2015 10-Q 10-Q filing on 08/05/2015 View Form
RGLS
Regulus Therapeutics
05/08/2015 10-Q 10-Q filing on 05/08/2015 View Form
RGLS
Regulus Therapeutics
02/19/2015 10-K 10-K filing on 02/19/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
66
ARQQ alert for Dec 28

Arqit Quantum [ARQQ] is down 3.22% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 4.72% over the past day.

Buy
62
ALGS alert for Dec 28

Aligos Therapeutics [ALGS] is down 4.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock